9 results about "Boswellia" patented technology

Pharmaceutical formulations and methods to increase the bioactivity and bioavailability of plant compound having hydrophobic phytochemicals which have poor bioavailability due to poor water solubility. Dispersions of extracts of Boswellia and / or Curcuma longa in sesame seed oil. Analgesic and anti-inflammatory composition having a) an extract of Boswellia, b) one or more of an extract of Curcuma longa, a curcuminoid composition and combinations thereof, and, c) a sesame seed oil. The analgesic and anti-inflammatory composition has particles having a particle size ranging from less than about 20 micrometers to about 1 micrometer. The analgesic and anti-inflammatory composition provides a total combined specific surface area provided by particles in the composition ranging from about 900 meter2 per kilogram to about 3000 meter2 per kilogram of the composition. Methods of preparing the compositions and methods of treating inflammation and musculoskeletal disorders are provided.

To provide a natural product-derived composition that allows for the easy intake of nutrients that can exhibit excellent functionality. [Solution] The composition comprises a collagen-containing extract derived from fish cartilage and a boswellic acid-containing extract derived from the Boswellia plant. The collagen-containing extract preferably contains type II collagen and type XI collagen, with a total mass ratio of their contents being 10:1 to 1:10, and a total content of 30% by mass or more. The boswellic acid-containing extract preferably contains 20% by mass or more of boswellic acid.

The invention belongs to the technical field of biological medicines, and particularly relates to a traditional Chinese medicine composition for treating orthopedic soft tissue injury and a preparation method thereof. The composition comprises the following raw materials in parts by weight: 4-6 parts of centella asiatica extract, 4-6 parts of salvia miltiorrhiza extract, 4-6 parts of pseudo-ginseng extract, 2-3.5 parts of eucommia ulmoides extract, 2-4 parts of liquorice extract, 4-7 parts of frankincense resin extract, 4-6.5 parts of turmeric extract and 3-4.5 parts of ligusticum wallichii extract. According to the invention, breakthrough is realized through prescription-drug delivery system-process triple synergy, and in prescription, the eight traditional Chinese medicine extracts are in multi-target synergy, and the whole process of anti-inflammation, analgesia and repair promotion is covered. On the delivery system, the hydrophilic component is included by cyclodextrin to be solubilized and stable, and the lipophilic component is efficiently transdermally loaded in the temperature-sensitive gel in the form of nanoemulsion to form a long-acting drug delivery bin on the skin. According to the process, microscopic uniformity and macroscopic stability of the system are ensured through precise low-temperature swelling, split-phase treatment and vacuum integration.

This invention discloses a strain of *Bosea vestrisii* and its application in promoting plant growth and improving salt tolerance. This strain is deposited at the China Center for Type Culture Collection (CCTCC) under accession number CCTCC M 2026307. *Bosea vestrisii* exhibits strong salt tolerance and possesses multiple growth-promoting functions, including secreting indoleacetic acid (IAA), synthesizing extracellular polysaccharides, and biological nitrogen fixation. Experiments show that applying this strain to wheat roots significantly increases plant height, root length, and biomass under salt stress, and enhances the activity of antioxidant enzymes (such as catalase, peroxidase, and superoxide dismutase) in the plant, effectively alleviating oxidative damage caused by salt stress. This invention provides a highly efficient and environmentally friendly microbial resource for improving saline-alkali soils, enhancing crop stress tolerance, and achieving sustainable agriculture.

The application discloses a medicine-moxibustion combined medicine composition for treating lung cancer cancer-induced fatigue and application thereof. The medicine-moxibustion combined medicine composition can effectively solve the problem of oral and navel moxibustion combined medicine for treating lung cancer cancer-induced fatigue. The medicine-moxibustion combined medicine composition comprises a first unit oral traditional Chinese medicine composition and a second unit navel moxibustion traditional Chinese medicine composition. The first unit oral traditional Chinese medicine composition is prepared from Chinese yam, radix codonopsis, poria cocos, rhizoma atractylodis macrocephalae, ganoderma lucidum, dried tangerine or orange peel, lablab bean, lotus seed, prepared licorice, amomum villosum, coix seed and platycodon grandiflorum, is soaked in water, is boiled with a strong fire, is boiled with a weak fire, is filtered, is concentrated under reduced pressure, is dried, is crushed, is uniformly prepared into soft material by adding an auxiliary material and using ethanol as a wetting agent, is sieved and granulated, is dried, is whole-granulated, and is packed, and the second unit navel moxibustion traditional Chinese medicine composition is prepared from astragalus root, rhizoma atractylodis macrocephalae, wind-preventing herb, galangal, dried ginger, costus root, dried tangerine or orange peel, agarwood, frankincense and boswellia, is uniformly prepared by crushing and mixing, is rich in raw materials, is scientific and reasonable, is easy to produce and prepare, is convenient to use, is safe in medicine use, is good in curative effect, and has actual clinical application value.

The present application relates to a kind of plant active ingredient extraction method, specifically to a kind of industrialized continuous preparation method of frankincense extract.The technical problem that the preparation method of existing frankincense extract is solved, using alkaline solvent, AKBA component is easily degraded, leading to the technical problem of the loss of the best active ingredient of frankincense extract.The method of the present application comprises the following steps: 1) the raw material of frankincense is extracted by methanol to obtain residue A and filtrate A;After the concentration of filtrate A, add anion polyacrylamide and filter, the filtrate is adsorbed and eluted by macroporous adsorption resin to obtain frankincense flavone;Residue A is extracted by alcohol organic solvent to obtain filtrate B and residue B;Residue B is extracted by water, concentrated, dried to obtain frankincense polysaccharide;2) filtrate B is first concentrated to alcohol degree 65%-75% and then adsorbed by adsorbent, and the supernatant is collected by filtration;The supernatant is concentrated to alcohol degree 10%-30%, and the first precipitate is obtained by filtration;3) add organic solvent C, stir and rinse, collect the second precipitate by filtration, and dry to obtain frankincense acid extract.

It relates to an oral composition comprising Epilobium parviflorum extract, Nigella sativa extract, and Boswellia serrata extract in specific amounts and ratios. It also relates to the oral composition for use in the treatment of hair loss. The present invention also relates to the use of the oral composition for improving brightness, hydration, elasticity, firmness, and / or hair shine; or for improving brightness, hydration, elasticity, and firmness of the skin.